UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013619
Receipt number R000015903
Scientific Title Analysis of chemotherapy induced-food preference alternation
Date of disclosure of the study information 2014/04/04
Last modified on 2019/04/12 10:35:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of chemotherapy induced-food preference alternation

Acronym

CHEF-PAL

Scientific Title

Analysis of chemotherapy induced-food preference alternation

Scientific Title:Acronym

CHEF-PAL

Region

Japan


Condition

Condition

Patients with solid tumor and hematologic malignancy who receive chemotherapy

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To analyze food preference in patients who receive chemotherapy and objective evaluation of taste intensities of foods using a Taste Sensor System

Basic objectives2

Others

Basic objectives -Others

Alternation of Zn, Cu, and Na in serum and incidence rate of adverse events based on NCI-CTCAE

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Identification of food preference alternation following chemotherapy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) patients with unresectable solid tumor and hematologic malignancy who receive chemotherapy
2) no prior chemotherapy / no radiation therapy
3) adequate use of antiemetics based on the Japanese Clinical Practice Guidelines
4) age 20 or over
5) The Eastern Cooperative Oncology Group(ECOG) Performance Status: 0~2
6) preserved organ functions
7) estimated prognosis >= 3 months
8) written informed consent was obtained

Key exclusion criteria

1) dysfunction of food intake and mastication
2) alimentary tract obstruction
3) prior local irradiation from oral cavity to esophagus
4) severe diabetes mellitus
5) uncontrolled non-malignant digestive diseases
6) other unacceptable reasons

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichiro Watanabe

Organization

Oita University Faculty Of Medicine Graduate School of Medicine

Division name

Department of Medical Oncology & Hematology

Zip code


Address

1-1 Idaigaoka, Hasama-machi Yufu-shi, Oita 879-5593 Japan

TEL

097-549-4411

Email

kwata@oita-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koichiro Watanabe

Organization

Oita University Faculty Of Medicine Graduate School of Medicine

Division name

Department of Medical Oncology & Hematology

Zip code


Address

1-1 Idaigaoka, Hasama-machi Yufu-shi, Oita 879-5593 Japan

TEL

097-549-4411

Homepage URL


Email

kwata@oita-u.ac.jp


Sponsor or person

Institute

Oita University Faculty Of Medicine Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Oita University Faculty Of Medicine Graduate School of Medicine, Department of Medical Oncology & Hematology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大分大学医学部附属病院(大分県)、大分県厚生連鶴見病院(大分県)、別府大学(大分県)


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 03 Month 17 Day

Date of IRB

2014 Year 03 Month 17 Day

Anticipated trial start date

2014 Year 04 Month 07 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

questionnaire survey, objective evaluation of taste intensities of foods using a Taste Sensor System


Management information

Registered date

2014 Year 04 Month 03 Day

Last modified on

2019 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015903